Symbiomics is a biotechnology company focused on developing high-performance biologicals containing efficient microbes for agriculture.
Symbiomics has raised $1.4M in total funding. The most recent round was Series A. The last funding was announced in June 2025.
Symbiomics's investors include The Yield Lab LATAM, Corteva Catalyst, Arar Capital, MOV Investimentos, Baraúna Venture Capital.
Symbiomics is headquartered in Florianópolis, Brazil.
Symbiomics is a biotechnology company focused on developing high-performance biologicals containing efficient microbes for agriculture.
Symbiomics is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Symbiomics — Funding & Investors." VCBacked, June 25, 2025, https://www.vcbacked.co/company/symbiomics. Accessed September 30, 2026.
VCBacked. (2025). Symbiomics — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/symbiomics
{{cite web |title=Symbiomics — Funding & Investors |url=https://www.vcbacked.co/company/symbiomics |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated